테넷 헬스케어 코퍼레이션
US ˙ NYSE ˙ US88033G4073

SecurityTHC / Tenet Healthcare Corporation
InsiderLynch Christopher S.
This page shows the track record and history of Lynch Christopher S. insider trades in Tenet Healthcare Corporation. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Lynch Christopher S. in THC / Tenet Healthcare Corporation. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

THC / Tenet Healthcare Corporation Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Lynch Christopher S. in THC / Tenet Healthcare Corporation. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2025-08-28 8 183.4400 8 183.4400 1,468 280 161.3700 -176 -12.00
2025-08-19 3,952 176.3900 3,952 176.3900 697,093
2024-05-30 10,861 133.8300 10,861 133.8300 1,453,528
2024-02-15 7,978 89.6000 7,978 89.6000 714,829

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

THC / Tenet Healthcare Corporation Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2026-05-26 2026-05-22 4 Lynch Christopher S. THC Common Stock M - Exercise D 1,333 13,405
2025-08-29 2025-08-28 4 Lynch Christopher S. THC Common Stock S - Sale D 183.4400 -8 -1 12,350
2025-08-21 2025-08-19 4 Lynch Christopher S. THC Common Stock S - Sale D 176.3900 -3,952 -697 12,358
2025-05-27 2025-05-23 4 Lynch Christopher S. THC Common Stock M - Exercise D 1,551 16,310
2024-06-03 2024-05-30 4 Lynch Christopher S. THC Common Stock S - Sale D 133.8300 -10,861 -1,454 14,759
2024-02-16 2024-02-15 4 Lynch Christopher S. THC Common Stock S - Sale D 89.6000 -7,978 -715 25,620
2023-06-23 2023-05-26 4/A Lynch Christopher S. THC Common Stock A - Award D 3,682 33,598
2023-05-30 2023-05-26 4 Lynch Christopher S. THC Common Stock A - Award D 2,846 32,762
2022-05-11 2022-05-09 4 Lynch Christopher S. THC Common Stock A - Award D 3,836 29,916
2021-05-11 2021-05-07 4 Lynch Christopher S. THC Common Stock A - Award D 3,960 26,080
2020-06-02 2020-05-29 4 Lynch Christopher S. THC Common Stock A - Award D 11,139 22,120
2019-09-04 2019-08-30 4 Lynch Christopher S. THC Common Stock A - Award D 10,981 10,981
P
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매입
S
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매각
A
자사로부터 유가증권(옵션 등)을 보조, 지급 또는 기타 취득
C
파생상품 전환
D
자사에게 유가증권을 매각 또는 양도
F
기업으로부터 인도 받은 유가증권의 일부를 사용한 행사 가격 또는 조세 채무의 지급
G
내부자에 의한 또는 내부자에게 증권 증여
K
지분스왑 및 유사 위험 회피거래
M
자사로부터 인도 받은 파생증권(옵션 등)의 행사 또는 전환
V
보고서 양식 4에 자진 신고된 거래
J
기타 (거래 내용을 설명하는 각주와 동반)